Holen Sie sich die Stockscreener-App
22.84
23.23%
-6.91
Onconova Therapeutics Inc Aktie (ONTX) Neueste Nachrichten
TRAWTraws Pharma Inc Stock Price and Quote - Finviz
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer - Yahoo Finance
Q4 2025 Traws Pharma Inc Earnings Call Transcript - GuruFocus
News | postregister.comOnconova Therapeutics, Inc.Common Stock (Nasdaq:ONTX) Stock Quote - FinancialContent
TransCode Therapeutics Appoints Jack E. Stover To Board - citybiz
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors - WV News
PI3K Inhibitors Clinical Trials Analysis 2025: Pipeline Analysis, Competitive Landscape, Emerging Therapies, Companies, and Future Outlook by DelveInsight - The Globe and Mail
Annovis Appoints Mark Guerin as Chief Financial Officer - citybiz
Rigosertib Shows Promise in EB-Associated Skin Cancer - Medscape
ONTX Stock Price, News & Analysis - Stock Titan
Huadong Medicine and Synerk to jointly develop siRNA drug - BioWorld MedTech
Onconova Therapeutics (NASDAQ: ONTXW)Share Price - intelligentinvestor.com.au
‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. - orrick.com
Traws Pharma (TRAW) Stock Price, News & Analysis - MarketBeat
10 High-Volume Penny Stocks and Trading Strategies - StocksToTrade
Onconova and Trawsfynydd merge to form Traws Pharma By Investing.com - Investing.com UK
PI3K Inhibitors Clinical Trial Pipeline Experiences - GlobeNewswire
We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully - Yahoo Finance
News - FinancialContent
Zim Doctor Appointed Chief Medical Officer in UK - ZimEye
Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference - FinancialContent
Penny Stocks To Buy Now? 5 With Big News Today - PennyStocks.com
Onconova Therapeutics Touts Additional Positive Data For Rigosertib Monotherapy In Skin Cancer Setting - Yahoo Finance
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors - citybiz
ONCONOVA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com
Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022 - The Globe and Mail
Corgi Onto 2X Daily ETF (ONTX-A) Stock Price and News - The Globe and Mail
Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug - Yahoo Finance
Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy - European Medical Journal
ONCONOVA THERAPEUTICS : ANNOUNCES PRICING OF $21 MILLION PUBLIC OFFERING OF COMMON STOCK - marketscreener.com
ONTX stock dives 16%, DVAX stock in green after clinical data - Kalkine Media
What's going on in today's pre-market session - ChartMill
Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer - GlobeNewswire
Why Onconova Therapeutics (ONTX) Stock Is Up Sharply - Market Realist
Onconova Therapeutics (ONTX) Stock Live Price, Chart & News - CoinCodex
ONTX Stock: Why Biopharma Onconova Therapeutics Is Shooting Higher Today - InvestorPlace
PrimoHoagies is on a roll, adding 21 stores, while Penn-backed Carisma raises cash to fight cancer - Inquirer.com
Novel CDK4/6 Inhibitor ON 123300 Receives Green Light to Move Into Phase 1 Testing in Relapsed/Refractory Advanced Cancers - OncLive
Onconova Therapeutics Appoints James J. Marino, JD, MBA as Chairman of the Board of Directors - citybiz
Onconova On The Edge After Phase III Rigosertib MDS Failure - Citeline News & Insights
Are These On Your List Of Penny Stocks To Trade This Week? - PennyStocks.com
Penny Stocks To Watch Before Next Week; 1 Up Over 370% In June 2020 - PennyStocks.com
Onconova Therapeutics Inc Files For Mixed Shelf Of Up To $150 Million - Reuters
ONTX Stock Price, Quote & Chart | ONCONOVA THERAPEUTICS INC (NASDAQ:ONTX) - ChartMill
ONCONOVA THERAPEUTICS INC (ONTX) Stock Technical Analysis - Chartmill
Bucks County biopharm firm names new CEO - The Business Journals
Onconova Therapeutics Announces New CEO Appointment - Global Banking & Finance Review
Hedge Fund and Insider Trading News: Michael Novogratz, Ray Dalio, Onconova Therapeutics Inc. (ONTX), Cerecor Inc (CERC), Spirit of Texas Bancshares Inc (STXB), L3 Technologies Inc (LLL), and More - Insider Monkey
Onconova Therapeutics Announces License Agreement With Pint Pharma To Commercialize Rigosertib - Reuters
Onconova Therapeutics Announces Closing of $10 Million - GlobeNewswire
Onconova Moving Forward with Phase 3 INSPIRE Pivotal Trial - GlobeNewswire
Onconova Therapeutics to Present at Biotech Showcase in January - GlobeNewswire
Onconova Therapeutics,Inc. (NASDAQ:ONTX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - marketexclusive.com
Onconova Therapeutics Announces Data on Improved - GlobeNewswire
Onconova Therapeutics Inc (ONTX): How Does It Impact Your Portfolio? - Yahoo Finance
Onconova Announces Two Presentations on Rigosertib in Myelodysplastic Syndromes at the ASH 2017 Annual Meeting - GlobeNewswire
Cellectar Biosciences enters into strategic collaboration with Onconova Therapeutics - Reuters
ONTEX Stock Price and Chart — EURONEXT:ONTEX - TradingView
ONTXOnconova Therapeutics Company Profile - StockInvest.us
Onconova Therapeutics, Inc. to Present at NobleCON13 - GlobeNewswire
Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2016 Financial Results - GlobeNewswire
Onconova Informs Stockholders of Key Dates Related to Announced Rights Offering - GlobeNewswire
Onconova Presents Clinical Data from Oral Rigosertib and - GlobeNewswire
Onconova Announces Presentations Highlighting IV Rigosertib - GlobeNewswire
Onconova Therapeutics, Inc. Announces Appointment of Jack E. Stover to Board of Directors - GlobeNewswire
Drug may best BSC in some high-risk MDS patients - MDEdge
Onconova Announces Data Presentation From Phase 2 - GlobeNewswire
Onconova Therapeutics, Inc. to Present New Data on - GlobeNewswire
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2015 Financial Results - GlobeNewswire
Onconova: Data Presentation From Combination Of Rigosertib And Azacitidine - RTTNews
Onconova To Present At Cowen Health Care Conference; Webcast At 11:20 AM ET - RTTNews
On the Boards - Inquirer.com
3.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):